ION BEAM APPLICATIONS (IBAB.BR) Stock Fundamental Analysis
Europe - Euronext Brussels - EBR:IBAB - BE0003766806 - Common Stock
15.28 EUR
+0.38 (+2.55%)
We assign a fundamental rating of 4 out of 10 to IBAB. IBAB was compared to 67 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of IBAB while its profitability can be described as average. IBAB has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- In the past year IBAB was profitable.
- In the past year IBAB had a positive cash flow from operations.
- Of the past 5 years IBAB 4 years were profitable.
- The reported operating cash flow has been mixed in the past 5 years: IBAB reported negative operating cash flow in multiple years.
1.2 Ratios
- With a Return On Assets value of 2.71%, IBAB perfoms like the industry average, outperforming 44.78% of the companies in the same industry.
- The Return On Equity of IBAB (14.29%) is better than 80.60% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 15.54%, IBAB belongs to the top of the industry, outperforming 92.54% of the companies in the same industry.
- IBAB had an Average Return On Invested Capital over the past 3 years of 6.20%. This is below the industry average of 9.84%.
- The 3 year average ROIC (6.20%) for IBAB is below the current ROIC(15.54%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROIC | 15.54% |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.2%
ROIC(5y)6.71%
1.3 Margins
- IBAB has a Profit Margin (2.85%) which is in line with its industry peers.
- In the last couple of years the Profit Margin of IBAB has declined.
- IBAB has a Operating Margin (6.48%) which is in line with its industry peers.
- IBAB's Operating Margin has improved in the last couple of years.
- The Gross Margin of IBAB (31.21%) is worse than 83.58% of its industry peers.
- IBAB's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% |
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IBAB is creating value.
- The number of shares outstanding for IBAB has been increased compared to 1 year ago.
- The number of shares outstanding for IBAB has been reduced compared to 5 years ago.
- IBAB has a worse debt/assets ratio than last year.
2.2 Solvency
- IBAB has an Altman-Z score of 1.77. This is a bad value and indicates that IBAB is not financially healthy and even has some risk of bankruptcy.
- With a Altman-Z score value of 1.77, IBAB is not doing good in the industry: 65.67% of the companies in the same industry are doing better.
- A Debt/Equity ratio of 0.23 indicates that IBAB is not too dependend on debt financing.
- IBAB has a Debt to Equity ratio of 0.23. This is in the better half of the industry: IBAB outperforms 70.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.77 |
ROIC/WACC2.09
WACC7.45%
2.3 Liquidity
- A Current Ratio of 0.94 indicates that IBAB may have some problems paying its short term obligations.
- IBAB has a worse Current ratio (0.94) than 83.58% of its industry peers.
- IBAB has a Quick Ratio of 0.94. This is a bad value and indicates that IBAB is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of IBAB (0.62) is worse than 82.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 112.86% over the past year.
- Measured over the past 5 years, IBAB shows a small growth in Earnings Per Share. The EPS has been growing by 3.99% on average per year.
- The Revenue has grown by 15.96% in the past year. This is quite good.
- Measured over the past years, IBAB shows a quite strong growth in Revenue. The Revenue has been growing by 12.01% on average per year.
EPS 1Y (TTM)112.86%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%75.35%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.7%
3.2 Future
- Based on estimates for the next years, IBAB will show a very strong growth in Earnings Per Share. The EPS will grow by 58.72% on average per year.
- Based on estimates for the next years, IBAB will show a small growth in Revenue. The Revenue will grow by 2.63% on average per year.
EPS Next Y141.9%
EPS Next 2Y109.12%
EPS Next 3Y67.72%
EPS Next 5Y58.72%
Revenue Next Year23.68%
Revenue Next 2Y13.14%
Revenue Next 3Y10.36%
Revenue Next 5Y2.63%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 26.81 indicates a quite expensive valuation of IBAB.
- 65.67% of the companies in the same industry are more expensive than IBAB, based on the Price/Earnings ratio.
- IBAB's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.32.
- With a Price/Forward Earnings ratio of 14.47, IBAB is valued correctly.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of IBAB indicates a rather cheap valuation: IBAB is cheaper than 80.60% of the companies listed in the same industry.
- IBAB's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.30.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.81 | ||
| Fwd PE | 14.47 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, IBAB is valued cheaper than 85.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.18 |
4.3 Compensation for Growth
- IBAB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as IBAB's earnings are expected to grow with 67.72% in the coming years.
PEG (NY)0.19
PEG (5Y)6.73
EPS Next 2Y109.12%
EPS Next 3Y67.72%
5. Dividend
5.1 Amount
- IBAB has a Yearly Dividend Yield of 1.18%.
- IBAB's Dividend Yield is a higher than the industry average which is at 0.95.
- Compared to the average S&P500 Dividend Yield of 1.86, IBAB is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 8.05% of the earnings are spent on dividend by IBAB. This is a low number and sustainable payout ratio.
DP8.05%
EPS Next 2Y109.12%
EPS Next 3Y67.72%
EBR:IBAB (1/21/2026, 7:00:00 PM)
15.28
+0.38 (+2.55%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-20 2025-11-20
Earnings (Next)03-27 2026-03-27/amc
Inst Owners27.85%
Inst Owner ChangeN/A
Ins Owners0.71%
Ins Owner ChangeN/A
Market Cap462.68M
Revenue(TTM)596.63M
Net Income(TTM)17.00M
Analysts80
Price Target15.56 (1.83%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.18% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP8.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.4%
PT rev (3m)3.98%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.78%
EPS NY rev (3m)-10.89%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)2.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.81 | ||
| Fwd PE | 14.47 | ||
| P/S | 0.78 | ||
| P/FCF | N/A | ||
| P/OCF | 166.19 | ||
| P/B | 3.89 | ||
| P/tB | 4.9 | ||
| EV/EBITDA | 10.18 |
EPS(TTM)0.57
EY3.73%
EPS(NY)1.06
Fwd EY6.91%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.09
OCFY0.6%
SpS19.7
BVpS3.93
TBVpS3.12
PEG (NY)0.19
PEG (5Y)6.73
Graham Number7.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROCE | 25.19% | ||
| ROIC | 15.54% | ||
| ROICexc | 16.45% | ||
| ROICexgc | 19.79% | ||
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% | ||
| FCFM | N/A |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.2%
ROIC(5y)6.71%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.19%
ROCE(5y)10.93%
ROICexgc growth 3YN/A
ROICexgc growth 5Y52.5%
ROICexc growth 3Y-88.2%
ROICexc growth 5Y50.32%
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
F-Score7
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.54 | ||
| Cap/Depr | 65.94% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 5.44% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 1.77 |
F-Score7
WACC7.45%
ROIC/WACC2.09
Cap/Depr(3y)79.57%
Cap/Depr(5y)64.6%
Cap/Sales(3y)2.05%
Cap/Sales(5y)1.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)112.86%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%75.35%
EPS Next Y141.9%
EPS Next 2Y109.12%
EPS Next 3Y67.72%
EPS Next 5Y58.72%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.7%
Revenue Next Year23.68%
Revenue Next 2Y13.14%
Revenue Next 3Y10.36%
Revenue Next 5Y2.63%
EBIT growth 1Y38.72%
EBIT growth 3Y27.16%
EBIT growth 5Y65.71%
EBIT Next Year221.54%
EBIT Next 3Y67.42%
EBIT Next 5Y52.9%
FCF growth 1Y90.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y105.87%
OCF growth 3YN/A
OCF growth 5YN/A
ION BEAM APPLICATIONS / IBAB.BR FAQ
Can you provide the ChartMill fundamental rating for ION BEAM APPLICATIONS?
ChartMill assigns a fundamental rating of 4 / 10 to IBAB.BR.
What is the valuation status of ION BEAM APPLICATIONS (IBAB.BR) stock?
ChartMill assigns a valuation rating of 5 / 10 to ION BEAM APPLICATIONS (IBAB.BR). This can be considered as Fairly Valued.
How profitable is ION BEAM APPLICATIONS (IBAB.BR) stock?
ION BEAM APPLICATIONS (IBAB.BR) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for IBAB stock?
The Price/Earnings (PE) ratio for ION BEAM APPLICATIONS (IBAB.BR) is 26.81 and the Price/Book (PB) ratio is 3.89.
Can you provide the dividend sustainability for IBAB stock?
The dividend rating of ION BEAM APPLICATIONS (IBAB.BR) is 3 / 10 and the dividend payout ratio is 8.05%.